QUOTE AND NEWS
Globe Newswire  Jul 25  Comment 
VANCOUVER, British Columbia, July 25, 2011 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) today announced it will hold a conference call to discuss the Q1-2011 financial results and to provide a corporate update. Cardiome will hold
Canadian Business  Mar 11  Comment 
VANCOUVER - Drug developer Cardiome Pharma Corp. (TSX:COM) swung to a loss in the fourth quarter, but still reported significantly improved
Canadian Business  Nov 11  Comment 
VANCOUVER - Cardiome Pharma Corp. (TSX:COM) says a US$30-million milestone payment from Merck resulted in dramatically higher third-quarter
Canadian Business  Oct 21  Comment 
VANCOUVER - Cardiome Pharma Corp. (TSX:COM) shares tumbled more than 13 per cent Thursday morning after a problem with one patient led to a
Canadian Business  Sep 2  Comment 
VANCOUVER - Drug developer Cardiome Pharma Corp. (TSX:COM) said Thursday it has earned a US$30-million milestone payment from a partnership with
StreetInsider.com  Aug 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cardiome+Pharma+Corp.+%28CRME%29+Misses+Q2+Views/5885634.html for the full story.
StreetInsider.com  May 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cardiome+Pharma+Corp.+%28CRME%29+Swings+to+Q1+Profit/5623656.html for the full story.
market folly  Dec 7  Comment 
This is the first time we've detailed portfolio changes of hedge fund Bridger Management so we felt it necessary to provide a bit of background first. Bridger Management is the hedge fund firm founded by Roberto Mignone in 2000. They currently...
Canadian Business  Aug 11  Comment 
VANCOUVER, B.C. - Cardiome Pharma Corp. (TSX:COM) says a 51 per cent drop in research and development spending and a jump in revenues from a





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki